|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Lantus (Insulin Glargine). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports primarily from April 2009 to March 2010. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (2527)
Cases resulting in a serious event (2442)
Cases resulting in death (195)
Cases resulting in life threatening events (64)
Cases resulting in hospitalization (832)
Cases resulting in disability (62)
Cases resulting in other serious reactions (1606)
Below is a sample of reports where side effects / adverse reactions may be related to Lantus (Insulin Glargine). For a complete list and/or a specific selection of reports, please use the links in the index above.
Possible Lantus side effects / adverse reactions in 17 year old male
Reported by a physician from United Kingdom on 2010-03-31
Patient: 17 year old male
Reactions: Cerebral Venous Thrombosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Novorapid
Dosage: unk
Indication: Type 1 Diabetes Mellitus
Lantus
Indication: Type 1 Diabetes Mellitus
Possible Lantus side effects / adverse reactions in female
Reported by a consumer/non-health professional from United States on 2010-03-31
Patient: female
Reactions: Device Malfunction
Suspect drug(s):
Solostar
Indication: Insulin-Requiring Type 2 Diabetes Mellitus
Lantus
Dosage: dose:80 unit(s)
Indication: Insulin-Requiring Type 2 Diabetes Mellitus
Possible Lantus side effects / adverse reactions in 64 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2010-03-31
Patient: 64 year old female
Reactions: Hypoglycaemia, Hyperhidrosis
Suspect drug(s):
Opticlick
Indication: Diabetes Mellitus
Start date: 2006-01-01
Lantus
Dosage: dose:60 unit(s)
Indication: Diabetes Mellitus
Start date: 2006-01-01
Possible Lantus side effects / adverse reactions in
Reported by a pharmacist from United States on 2010-03-31
Patient:
Reactions: Device Malfunction
Suspect drug(s):
Solostar
Lantus
Possible Lantus side effects / adverse reactions in male
Reported by a consumer/non-health professional from United States on 2010-03-31
Patient: male
Reactions: Device Malfunction
Suspect drug(s):
Solostar
Lantus
Dosage: dose:50 unit(s)
Start date: 2005-05-01
Possible Lantus side effects / adverse reactions in female
Reported by a consumer/non-health professional from United States on 2010-03-31
Patient: female
Reactions: Device Malfunction
Suspect drug(s):
Solostar
Lantus
Possible Lantus side effects / adverse reactions in female
Reported by a physician from Italy on 2010-03-31
Patient: female
Reactions: Hypoglycaemia, Asthenia, Hypokalaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Novorapid Flexpen
Dosage: 23 u, qd
Indication: Diabetes Mellitus
Start date: 2009-02-13
Lantus
Dosage: 14 u, qd
Indication: Diabetes Mellitus
Start date: 2009-02-13
Metforal
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2009-02-13
Other drugs received by patient: Losazid
Possible Lantus side effects / adverse reactions in male
Reported by a consumer/non-health professional from United States on 2010-03-31
Patient: male
Reactions: Device Malfunction
Suspect drug(s):
Solostar
Lantus
Possible Lantus side effects / adverse reactions in 86 year old male
Reported by a consumer/non-health professional from Brazil on 2010-03-30
Patient: 86 year old male, weighing 60.0 kg (132.0 pounds)
Reactions: Bowel Movement Irregularity, Jaundice, Dyspnoea, Vomiting, Pancreatic Neoplasm, Diarrhoea, Dysuria, Septic Shock, Blood Glucose Increased, Infection, Infarction
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Lantus
Indication: Type 2 Diabetes Mellitus
End date: 2010-02-18
Optipen
End date: 2010-02-18
Other drugs received by patient: Glucovance; Simvastatin; Cilostazol; NPH Insulin; Novorapid
Possible Lantus side effects / adverse reactions in female
Reported by a consumer/non-health professional from United States on 2010-03-30
Patient: female
Reactions: Confusional State, Somnolence, Convulsion, Speech Disorder, Blood Glucose Decreased, Tongue Biting, Altered State of Consciousness, Shock Hypoglycaemic
Suspect drug(s):
Novolog
Dosage: 1 unit per 15 grams of carbohydrates
Indication: Type 1 Diabetes Mellitus
Lantus
Dosage: 25 iu, qd
Indication: Type 1 Diabetes Mellitus
Start date: 2009-01-01
Possible Lantus side effects / adverse reactions in 62 year old male
Reported by a consumer/non-health professional from United States on 2010-03-30
Patient: 62 year old male
Reactions: Renal Function Test Abnormal, Dehydration, Blood Potassium Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Lantus
Dosage: dose:20 unit(s)
Indication: Type 2 Diabetes Mellitus
Start date: 2010-03-18
Solostar
Indication: Type 2 Diabetes Mellitus
Start date: 2010-03-18
Other drugs received by patient: Glucophage; Diuretics; Niaspan; Fenofibrate
Possible Lantus side effects / adverse reactions in male
Reported by a consumer/non-health professional from United States on 2010-03-30
Patient: male
Reactions: Drug Ineffective, Device Malfunction
Suspect drug(s):
Solostar
Lantus
Possible Lantus side effects / adverse reactions in 87 year old female
Reported by a consumer/non-health professional from United States on 2010-03-30
Patient: 87 year old female
Reactions: Cataract, Neuropathy Peripheral, Pneumonia, Retinal Disorder, Macular Degeneration
Suspect drug(s):
Lantus
Dosage: dose:46 unit(s)
Indication: Insulin-Requiring Type 2 Diabetes Mellitus
Opticlick
Indication: Insulin-Requiring Type 2 Diabetes Mellitus
Possible Lantus side effects / adverse reactions in 78 year old female
Reported by a individual with unspecified qualification from France on 2010-03-30
Patient: 78 year old female
Reactions: Insulin-Requiring Type 2 Diabetes Mellitus, Anaemia, Atrial Fibrillation, Clostridium Difficile Colitis, Hyponatraemia, Cardiac Disorder, Gastritis, Hypokalaemia, Anxiety, Cardiac Failure, Dehydration, Oedema, Hypertension, Erysipelas, Renal Failure Acute
Adverse event resulted in: death
Suspect drug(s):
Levothyroxine Sodium
Dosage: 1 dosage forms (1 dosage forms, 1 in 1 d)
Administration route: Oral
Indication: Hypothyroidism
Start date: 1993-01-01
End date: 2009-10-27
Augmentin (Amoxicilline, Clavulanic Acid)
Dosage: 1 g/day for 10 days per month
Administration route: Oral
Indication: Erysipelas
Start date: 2009-08-04
End date: 2009-10-07
Inexium (40 MG, Gastro-Resistant Tablet) (Esomeprazole Magnesium)
Dosage: 1 dosgage forms (1 dosage forms, 1 in 1 d)
Administration route: Oral
Indication: Gastritis
Start date: 2008-08-01
End date: 2009-10-27
Previscan (20 MG, Tablet) (Pentoxifylline)
Dosage: 5 mg (5 mg, 1 in 1 d)
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 1993-01-01
End date: 2009-10-27
Ramipril
Dosage: 7.5 mg (7.5 mg,1 in 1 d)
Administration route: Oral
Indication: Hypertension
Start date: 2009-04-03
End date: 2009-10-07
Cordarone
Dosage: 200 mg 5/7 days
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 1994-11-01
End date: 2009-10-27
Lasix
Dosage: 80 mg (40 mg, 2 in 1 d)
Indication: Oedema DUE TO Cardiac Disease
Start date: 2008-01-01
End date: 2009-10-07
Kaleorid LP (600 MG, Modified-Release Tablet) (Potassium Chloride)
Dosage: 1 dosage forms (1 dosage forms, 1 in 1 d)
Administration route: Oral
Indication: Hypokalaemia
Start date: 2008-01-01
End date: 2009-10-07
Folic Acid
Dosage: 1 dosage forms (1 dosage forms, 1 in 1 d)
Administration route: Oral
Indication: Anaemia
End date: 2009-10-07
Dafalgan (500 MG, Capsule) (Paracetamol)
Dosage: on request
Administration route: Oral
Indication: Analgesic Intervention Supportive Therapy
Start date: 1990-01-01
End date: 2009-10-07
Lorazepam
Dosage: 1 dosage forms (1 dosage forms, 1 in 1 d)
Administration route: Oral
Indication: Anxiety
Start date: 1991-01-01
End date: 2009-10-07
Lantus
Dosage: 22 iu (22 iu, 1 in 1 d)
Indication: Insulin-Requiring Type 2 Diabetes Mellitus
Start date: 2004-01-01
End date: 2009-10-24
Possible Lantus side effects / adverse reactions in female
Reported by a consumer/non-health professional from South Africa on 2010-03-30
Patient: female
Reactions: Product Quality Issue, Device Malfunction
Suspect drug(s):
Solostar
Lantus
Possible Lantus side effects / adverse reactions in 84 year old male
Reported by a consumer/non-health professional from United States on 2010-03-30
Patient: 84 year old male
Reactions: Abdominal Pain, Rhabdomyolysis, Pneumonia, International Normalised Ratio Increased, Blood Pressure Decreased, Blood Glucose Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Lantus
Other drugs received by patient: Omeprazole; Metoprolol Tartrate
Possible Lantus side effects / adverse reactions in 81 year old male
Reported by a consumer/non-health professional from United States on 2010-03-30
Patient: 81 year old male
Reactions: Cataract
Suspect drug(s):
Lantus
Dosage: dose:55 unit(s)
Indication: Diabetes Mellitus
Apidra
Dosage: per sliding scale 2-3 times per day
Opticlick
Indication: Diabetes Mellitus
Opticlick
Possible Lantus side effects / adverse reactions in female
Reported by a consumer/non-health professional from Brazil on 2010-03-29
Patient: female, weighing 45.0 kg (99.0 pounds)
Reactions: Hyperglycaemia, Ketoacidosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Lantus
Start date: 2009-05-01
Solostar
Start date: 2009-05-01
Other drugs received by patient: Humalog; Puran T4
Possible Lantus side effects / adverse reactions in 56 year old female
Reported by a physician from Japan on 2010-03-29
Patient: 56 year old female, weighing 64.3 kg (141.5 pounds)
Reactions: Hepatic Function Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Lantus
Dosage: dose:8 unit(s)
Indication: Diabetes Mellitus
End date: 2010-03-02
Solostar
Indication: Hyperglycaemia
End date: 2010-03-02
Other drugs received by patient: Mevalotin; Pioglitazone HCL; Miglitol; Flomox; Lorcam
Possible Lantus side effects / adverse reactions in 45 year old female
Reported by a consumer/non-health professional from United States on 2010-03-29
Patient: 45 year old female
Reactions: Breast Cancer
Suspect drug(s):
Lantus
Dosage: dose:20 unit(s)
Indication: Type 2 Diabetes Mellitus
Start date: 2009-01-01
Opticlick
Indication: Type 2 Diabetes Mellitus
Start date: 2009-01-01
Possible Lantus side effects / adverse reactions in 42 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2010-03-29
Patient: 42 year old female
Reactions: Hyperglycaemia, Device Malfunction
Suspect drug(s):
Solostar
Indication: Type 1 Diabetes Mellitus
Lantus
Dosage: dose:26 unit(s)
Indication: Type 1 Diabetes Mellitus
Other drugs received by patient: Humalog; ALL Other Therapeutic Products
Possible Lantus side effects / adverse reactions in 60 year old male
Reported by a consumer/non-health professional from United States on 2010-03-29
Patient: 60 year old male
Reactions: Blindness, Corrective Lens User
Suspect drug(s):
Lantus
Dosage: dose:70 unit(s)
Indication: Type 1 Diabetes Mellitus
Start date: 2006-01-01
Solostar
Possible Lantus side effects / adverse reactions in 42 year old male
Reported by a consumer/non-health professional from United States on 2010-03-29
Patient: 42 year old male
Reactions: Heart Transplant
Suspect drug(s):
Lantus
Dosage: dose:50 unit(s)
Start date: 2005-05-01
Solostar
Possible Lantus side effects / adverse reactions in 13 year old female
Reported by a consumer/non-health professional from United States on 2010-03-29
Patient: 13 year old female
Reactions: Hyperglycaemia, Device Malfunction
Suspect drug(s):
Solostar
Indication: Type 1 Diabetes Mellitus
Start date: 2010-02-01
Lantus
Dosage: dose:34 unit(s)
Indication: Type 1 Diabetes Mellitus
Start date: 2010-02-01
Possible Lantus side effects / adverse reactions in 72 year old male
Reported by a consumer/non-health professional from Brazil on 2010-03-29
Patient: 72 year old male, weighing 62.0 kg (136.4 pounds)
Reactions: Weight Decreased, Intestinal Polyp, Hyperglycaemia, Gastrointestinal Carcinoma
Suspect drug(s):
Lantus
Indication: Type 2 Diabetes Mellitus
Start date: 2006-04-01
End date: 2007-01-01
Lantus
Start date: 2007-01-01
Optipen
Start date: 2006-04-01
Autopen 24
Puran T4
Administration route: Oral
Indication: Thyroid Disorder
Other drugs received by patient: Benerva
|
